'I'm a spinal surgeon – here's how your posture is killing your back'
Dr. Arthur L. Jenkins III, a board-certified neurosurgeon in New York — who is also fellowship-trained in spinal surgery and CEO of Jenkins NeuroSpine — blamed slouching and poor posture for grave effects on the back.
Poor posture stretches the spine in a way it's "really not designed to do," Jenkins said in an interview with Fox News Digital.
Just 1 In 10 Back Pain Treatments Work, Study Says – What To Do Instead
"We stand much better than we sit," he said. "And we find more people having that pain when they're working or when they've been sitting for a while – it's just a terrible position for our spines."
"Tech neck," or excessive forward posture, is caused by looking down at devices, including phones and laptops, the expert noted.
Read On The Fox News App
Being in this "suboptimal" position while sitting down for long periods of time can be damaging.
'Dead Butt Syndrome' Could Happen After Sitting Too Long, Here's How To Avoid The Condition
"At night, a lot of people will [watch] TV … and their chin is tucked down," Jenkins said. "Most people don't put TVs on their ceilings."
This position can lead to a condition called kyphosis, where the front of the spine is strained and extra pressure lands on the disks.
This posture also stretches and pulls on the muscles in the lower back as they are forced to "stretch out and give," said Jenkins.
"All the muscles are designed to be at their strongest when your spine is in its optimum position," he said. "Once you get out of the optimum position, your muscles have to work harder to maintain that."
For those who work in front of screens all day, Jenkins recommends standing up often and stretching out the body to keep the joints "lubricated and active."
It can help to use a standing desk, raise the computer monitor higher to promote an elevated chin and neck angle, or sit on an exercise ball instead of a desk chair, he advised.
Ask A Doctor: 'Is It Dangerous To Crack My Neck Or Back?'
Even while sitting on the couch, Jenkins said it's best to sit up, avoid slouching and change positions every so often.
Isolating and flexing the back and ab muscles can also help to promote healthy muscles and ward off back pain.
"Find ways to be more mindful during the day of engaging your core," Jenkins advised. "While you're sitting there, squeeze your abdominal and back muscles together."
Ask A Doctor: 'How Can I Improve My Posture?'
"Even if you don't do a formal sit-up, if you just spend five minutes mindfully squeezing your core while you're working, that's better than not doing anything at all."
Maintaining flexibility, especially with age, can also help prevent back pain.
Jenkins recommends committing to a fitness routine that "speaks to your issues" while strengthening the core and stretching the muscles, like yoga or Pilates.
Jenkins also warned people to avoid "BLT" — or bending, lifting and twisting all at once, which is a major contributor to back pain.
"You should always try to break up your bending, lifting and twisting into individual components … You should never bend, lift and twist at the same time," he instructed.
"When you lift, engage your core actively. Think about squeezing your core while you're lifting anything."
A new study out of Italy, published in the journal Healthcare, found that a kinesiology-based method can be effective in treating lower back pain.
Noting that lower back pain is the leading cause of disability worldwide, the researchers introduced the Canali Postural Method (CPM) to a group of individuals for three months.
For more Health articles, visit www.foxnews.com/health
CPM, which is a personal kinesiological therapy to reprogram posture, showed promise in improving motor control and quality of life, and suggested "potential benefits for other musculoskeletal issues," the study found.
Although the international study only included 35 participants, Jenkins said the results speak to the effectiveness of a "very structured, posture-based exercise regimen."
"It's pretty straightforward that more support is better," he said.
"Kinesiology, chiropractic or just general physical therapy, or Pilates, or yoga – any of these interventions are likely to provide more support for the person's back, and better pain relief than them trying to figure it out for themselves."
Jenkins recommends seeing a professional if back pain persists and prevents engagement in normal activities.
Click Here To Sign Up For Our Health Newsletter
It is also best to seek medical attention if the pain does not subside after trying exercise, therapy or anti-inflammatory medications.
Any emergent signs that surface – such as severe pain, worsened balance, or impaired bladder or bowel function – should be addressed immediately by a doctor, according to Jenkins.Original article source: 'I'm a spinal surgeon – here's how your posture is killing your back'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
5 hours ago
- Miami Herald
Hershey makes major change candy lovers may not have seen coming
For those with a sweet tooth, candy is the ultimate guilty pleasure. Whether chocolate, lollipops, or gummies, these treats are undeniably addictive. Let's be honest. We often tell ourselves we'll just have one bite, but once we get a taste, it's nearly impossible to stop. Don't miss the move: Subscribe to TheStreet's free daily newsletter Many of us can relate to hiding candy from our parents as kids so they wouldn't lecture us on how bad it is for our health. Now that we are adults, we have no one to prevent us from eating an entire box of chocolates in one sitting, except ourselves. Related: Hershey adds new products to move beyond chocolate Most people aren't trying to cut out candy just because it's high in calories; they're also concerned about the added sugars, lack of nutrients, and potential health risks that come with it. Yet, the ingredients list often gets overlooked, which can be nearly as long and difficult to pronounce as a college philosophy book. Image source: Getty Images The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) recently kicked off various new measures to phase out six petroleum-based synthetic dyes from the nation's food supply by the end of next year. The intent is to encourage natural alternatives, as synthetic dyes may be linked to childhood diabetes, obesity, depression, and ADHD. Related: Hershey creates new guilt-free candy that's a dream combo "For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent," said HHS Secretary Robert F. Kennedy, Jr. "These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and era is coming to an end." This request has reached multiple states, with West Virginia becoming the first state to ban the sale of food containing artificial dyes and preservatives beginning in 2028. Texas will now require warning labels on food products containing synthetic dyes starting in 2027. Major food companies, including ConAgra Brands (CAG) , General Mills (GIS) , Tyson Foods (TSN) , and W.K. Kellogg (KLG) , have recently joined the initiative by committing to completely remove synthetic dyes by the end of 2027, with Nestlé USA (NSRGY) aiming for mid-2026. Now, Hershey (HSY) , the largest chocolate manufacturer in the U.S., is hopping on the trend, promising to remove synthetic dyes from its products by the end of 2027. More Food News: Starbucks' huge new rival opens first US storesMcDonald's brings back experimental menu item 13 years laterOreo listens to fans and brings back flavor after nearly a decade Many of the company's products, including Jolly Ranchers, Twizzlers, and Reese's Pieces, rely on synthetic dyes, and removing them would require a hefty investment if it wants to fulfill its promise. Hershey acknowledges that making these changes would increase consumer costs, but removing the dyes will provide customers with more options, while ensuring confidence and trust in its products. However, finances might be a bit tight, since net sales in its North America Confectionery sector fell 15% in the first quarter of 2025 compared to last year. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
6 hours ago
FDA vaccine official restricted COVID vaccine approvals against agency advice
WASHINGTON -- The government's top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. The new memos from the Food and Drug Administration show how the agency's vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna. Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the shots for everyone 12 and older, similar to previous COVID vaccines. The scientists had concluded the benefit from the vaccines and the risk of COVID-19 outweighed the risk of possible side effects, which are rare. Instead Prasad decided the shots should be limited to those who face special risks from the virus— seniors or children and adults with underlying medical issues. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects. It's the latest in a series of vaccine restrictions imposed by officials working under Kennedy, who has long questioned the benefits of vaccines. 'Even rare vaccination related harms both known and unknown now have higher chance of outweighing potential benefits' Prasad wrote in a five-page memo explaining his decision. COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months. Top FDA leaders are typically not involved in the review of individual products. Officials like Prasad can overrule staffers, but such cases are rare and often controversial. News of the FDA documents was first reported by the New York Times. Prasad was hired to lead the FDA's vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy. An academic researcher specializing in cancer therapies, Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. Since arriving at the agency he has worked with FDA Commissioner Mark Makary on new guidelines that will limit approvals of future COVID boosters to higher-risk Americans, mainly seniors and those with medical conditions like asthma and obesity. Those limits match the terms FDA recently approved for Novavax's shot, Nuvaxovid and Moderna's mNexspike. Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S. Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine. The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that 'the risk-benefit assessment for this vaccine technology remains favorable.' FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot. Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. In his 'override memo,' reversing FDA staff's decision on the Moderna shot, Prasad pointed to the ongoing risk of myocarditis and questions about its frequency. The agency ordered Moderna to conduct further studies of the risk as a condition for the approving its updated shot. A spokesman for the administration said Prasad 'has raised serious concerns' about the issue. 'We will not ignore these risks and will ensure that the gold standard of science is used for any decisions,' said Andrew Nixon, in an emailed statement. Outside researchers have noted that cases of the heart condition tend to resolve quickly and are less severe than those associated with COVID infection itself, which can also cause myocarditis. ___
Hamilton Spectator
7 hours ago
- Hamilton Spectator
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
WASHINGTON (AP) — The government's top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. The new memos from the Food and Drug Administration show how the agency's vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna. Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the shots for everyone 12 and older, similar to previous COVID vaccines. The scientists had concluded the benefit from the vaccines and the risk of COVID-19 outweighed the risk of possible side effects, which are rare. Instead Prasad decided the shots should be limited to those who face special risks from the virus— seniors or children and adults with underlying medical issues. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects. It's the latest in a series of vaccine restrictions imposed by officials working under Kennedy, who has long questioned the benefits of vaccines. 'Even rare vaccination related harms both known and unknown now have higher chance of outweighing potential benefits' Prasad wrote in a five-page memo explaining his decision. COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months. Top FDA leaders are typically not involved in the review of individual products. Officials like Prasad can overrule staffers, but such cases are rare and often controversial. News of the FDA documents was first reported by the New York Times. Prasad was hired to lead the FDA's vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy. An academic researcher specializing in cancer therapies , Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. Since arriving at the agency he has worked with FDA Commissioner Mark Makary on new guidelines that will limit approvals of future COVID boosters to higher-risk Americans, mainly seniors and those with medical conditions like asthma and obesity. Those limits match the terms FDA recently approved for Novavax's shot, Nuvaxovid and Moderna's mNexspike. Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S. Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine. The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that 'the risk-benefit assessment for this vaccine technology remains favorable.' FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot. Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. In his 'override memo,' reversing FDA staff's decision on the Moderna shot, Prasad pointed to the ongoing risk of myocarditis and questions about its frequency. The agency ordered Moderna to conduct further studies of the risk as a condition for the approving its updated shot. A spokesman for the administration said Prasad 'has raised serious concerns' about the issue. 'We will not ignore these risks and will ensure that the gold standard of science is used for any decisions,' said Andrew Nixon, in an emailed statement. Outside researchers have noted that cases of the heart condition tend to resolve quickly and are less severe than those associated with COVID infection itself, which can also cause myocarditis. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
